Aurora Cannabis Inc ACB
Annual
Quarterly
No annual revenue total was found in AURORA CANNABIS INC's SEC filings.
Aurora Cannabis Inc (ACB) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
56.23M
+3.1% vs prior year
Net cash
—
Operating margin
—
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- ACB (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Edmonton, Alberta, Canada
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1683541
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 4, 2026 | Nov 3, 2026 |
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Nov 3, 2026 |
| 6-K | Current report (foreign issuer) | Oct 29, 2026 | Oct 29, 2026 |
| 6-K | Current report (foreign issuer) | Oct 26, 2026 | Oct 26, 2026 |
| 6-K | Current report (foreign issuer) | Oct 14, 2026 | Oct 14, 2026 |
| 6-K | Current report (foreign issuer) | Oct 8, 2026 | Oct 8, 2026 |
All 431 Aurora Cannabis Inc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.